Market Tracker

10/31 7:05pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

4.94
Data as of 3:56pm ET
 +0.10 / +2.07%
Today’s Change
4.52
Today|||52-Week Range
50.00
-55.50%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close4.84
Today’s open4.92
Day’s range4.69 - 4.97
Volume19,114
Average volume (3 months)20,662
Market cap$62.6M
Dividend yield--
Data as of 3:56pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+26.32%
Earnings growth (this year)+93.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.38%
P/E ratio1.6
Price/Sales1.73
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
ADXSAdvaxis Inc-0.02-0.63%
PARNParnell Pharmaceutic...+0.10+2.15%
APRIApricus Biosciences ...-0.10-6.33%
IPCIIntelliPharmaCeutics...+0.04+1.43%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$14.7M
Annual profit (last year)-$38.6M
Net profit margin-262.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts